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This study was conducted to evaluate the relationship between leukemia occurrence and long-
term, low-level benzene exposures in petroleum distribution workers. Fourteen cases were
identified among a previously studied cohort [Schnatter et al., Environ Health Perspect 101 (Suppl
6):85-99 (1993)]. Four controls per case were selected from the same cohort, controlling for birth
year and time at risk. Industrial hygienists estimated workplace exposures for benzene, without
knowledge of case-control status. Average benzene concentrations ranged from 0.01 to 6.2 ppm.
Company medical records were used to abstract information on other potential confounders such
as cigarette smoking. Odds ratios were calculated for several exposure metrics. Conditional
logistic regression modeling was used to control for potential confounders. The risk of leukemia
was not associated with increasing cumulative exposure to benzene for these exposure levels.
Duration of benzene exposure was more closely associated with leukemia risk than other
exposure metrics, although results were not statistically significant. A family history of cancer and
cigarette smoking were the two strongest risk factors for leukemia, with cumulative benzene
exposure showing no additional risk when considered in the same models. This study is
consistent with other data in that it was unable to demonstrate a relationship between leukemia
and long-term, low-level benzene exposures. The power of the study was limited. Thus, further
study on benzene exposures in this concentration range are warranted. Environ Health
Perspect 104(Suppl 6):1375-1379 (1996)
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Introduction
Benzene has been classified as a known concentrations of50 ppm (7,8). Petroleum
human carcinogen (1). Most investigators distribution workers are exposed to benzene
(2-5) base risk predictions for occupa- while transferring gasoline and other petro-
tional and environmental exposures on a leum products. These exposure levels are
cohort of rubber hydrochloride workers generally less than 1 ppm on an 8-hr time-
(6). However, this cohort was exposed to weighted average basis. Previous studies of
high concentrations of benzene, which these workers (9-12) have not examined
sometimes exceeded time-weighted average leukemia risk by benzene exposure. The
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aim of this article is to study this lower
portion of the dose-response curve for
benzene and leukemia.
Methods
We identified cases from all workers in a
previously conducted cohort study (13)
meeting the following criteria: a) died with
an underlying cause of death of leukemia
(International Classification ofDisease,
codes 204-207); b) ever worked in either
the marketing/distribution, marine, or
pipeline segments; and c) died between
1964 and 1983, the study end date.
Statistics Canada coded all death certifi-
cates for underlying cause of death. The
criteria resulted in 16 leukemias. We were
unable to obtain reliable information on
leukemia cell types for the cases. We
selected four controls for each case from
records in the same cohort. Controls were
restricted to males, frequency matched by
decade of birth, and were alive on or after
the case's date of death. After excluding
cases and controls with inadequate work
histories, there were 14 leukemia cases and
55 controls.
The details of the exposure assessment
strategy are described elsewhere (14).
Briefly, work histories were abstracted from
hard copy personnel records for each case
and control and forwarded, without case/
control status to industrial hygienists. The
industrial hygienists derived workplace
exposure estimates for benzene and total
hydrocarbons for every job/location/era
combination. The process started with site
characterizations for the 89 study locations,
including loading/unloading technology
present at the sites, the types of materials
handled, the typical tasks performed by
workers, and typical environmental condi-
tions such as average ambient tempera-
tures. Surveys were available for some of
the sites and were supplemented with data
on similar operations from outside the
company to derive "base exposure esti-
mates" for job/location/era scenarios in the
work histories. The industrial hygienists
then applied adjustment factors, based on
differences in environmental, operational,
task, and worksite conditions. The values
for the adjustment factors were estimated
through physical-chemical first principles,
or empirical data.
The validity of the estimating method
was tested by comparing exposure estimates
from the estimating procedure with results
from industrial hygiene surveys carried out
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during the relevant time period. On
average, estimates were within 22% of the
measured data. This was considered
reasonable agreement.
Eight-hour time-weighted average
exposure intensity estimates were assigned
to each line in every worker's job/location
history. We subtracted absentee informa-
tion from time at work, and then multi-
plied the intensity estimates by length of
time in a job. These results were summed
to arrive at a ppm-year estimate for every
worker's career. Exposures for controls
were only summed up to the correspond-
ing case's date of death. We also lagged
exposures by 5, 10, and 15 years (15). This
strategy does not count exposures received
5, 10, or 15 years immediately prior to the
case's date ofdeath. The industrial hygien-
ists also provided a ranked estimate for
each line indicating the probability ofder-
mal exposure to hydrocarbons. This was
kept as a separate index from the estimated
inhalation concentrations.
Potential confounders were abstracted
from company medical records, and
included information on smoking habits,
hobbies, previous exposures and occupa-
tions, diagnostic radiation exposure, and
family history of cancer. The dependent
variable in all analyses was case/control
status. The primary independent variable
of interest is cumulative benzene exposure
measured in ppm-years. Other exposure
characterizations, such as dermal exposure
and average intensity of exposure during
the entire work history, were also analyzed.
We also categorized cumulative exposure
in various ways to guard against a cutpoint
effect (16). We examined results according
to the following schemes using the distrib-
ution ofexposures in the controls:
* the quartile distribution
* the tertile distribution
* four categories split at the median,
75th, and 90th percentiles
* ppm-years split at 0.45, 4.5, and 45
ppm-years (the category boundaries
correspond to 0.01, 0.1 ppm, and 1
ppm for 45 years)
* ppm-years split at 0.9, 9.9, and 99
ppm-years (the category midpoints
correspond to 0.01, 0.1, and 1.0 ppm
for 45 years).
Results
The mean ages (at first exposure and last
follow up) and number ofyears exposed,
are displayed in Table 1 for leukemia cases
and controls. On average, the leukemia cases
were three years younger than controls.
Table 1. Comparison of attributes for leukemia cases
and controls.
Characteristic Cases Controls
Age, at case's death 68.5 68.0
Age, atfirst exposure 28.7 31.7
Years exposed 30.3 28.0
Table 2. Leukemia risk by potential confounders.
No.
exposed Odds
cases ratio 95% Cl
Socioeconomic job type
Managerial/professional 4 1.00
Clerk/technician 4 0.34 0.03-3.10
Operator/driver 6 0.41 0.07-2.33
Smoking status
Never 0 1.00
Ever 7 00
Familial cancer
No 8 1.00
Yes 5 2.51 0.51-13.3
No. chest X-rays
0-9 7 1.00
10-14 3 1.41 0.18-11.2
15-19 2 0.75 0.01-18.8
20+ 1 1.73 0.02-156
Cl, confidence interval.
Cases were also exposed for a similar
number ofyears as controls.
Table 2 displays matched odds ratios
(ORs) for the 14 leukemia cases and 55
controls according to potentially confound-
ing variables. The two strongest risk factors
are a family history of cancer (OR=2.51),
and smoking (OR=°), although both
have wide or noncalculable confidence
intervals. The number ofchest X-rays doc-
umented in medical records is not strongly
related to leukemia risk, while the risk of
leukemia is highest in managerial and
professional job designations.
Table 3 shows the risk of leukemia
according to cumulative exposure to ben-
zene. None ofthe categorizations shows a
monotonic trend for leukemia risk by
cumulative exposure, although there are a
small number ofcases and controls in each
category. For cumulative benzene exposure,
the highest leukemia risks are observed in
the second quartile (OR= 5.06) and mid-
dle tertile (OR=4.37), but the ORs
decrease in the highest quartiles and tertile.
When examining the highest exposure
categories in Table 3, cumulative benzene
exposures greater than 5.5, 8, 20, 45, and
99.9 (up to 220 ppm-years) result in ORs
of0.92, 2.11, 0.96, 1.47, and 1.03, respec-
tively. All five ofthe categorizations suggest
risks consistent with unity for the highest
Table3.Leukemia riskbycumulative exposureto benzene.
No.
Benzene exposure, exposed Odds
ppm-years cases ratio 95% Cl
0-0.17a 2 1.00
0.18-0.49 8 5.06 0.34-295
0.50-7.9 1 0.88 0.01-18.2
8.0-219.8 3 2.11 0.10-138
0-0.22b 3 1.00
0.23-5.49 8 4.37 0.72-48.6
5.50-219.8 3 0.92 0.10-11.2
0-0.49c 10 1.00
0.50-7.99 1 0.22 0-1.82
8.0-19.99 1 0.42 0.01-3.95
20.0-219.8 2 0.96 0.09-6.81
0-0.45d 10 1.00
>0.45-4.5 1 0.43 0.01-4.05
>4.5-45 1 0.16 0-1.32
>45 2 1.47 0.16-13.1
0-0.90d 10 1.00
>0.90-9.9 2 0.43 0.04-2.36
>9.9-99.9 1 0.48 0.01-4.55
>99.9 1 1.03 0.02-20.3
aCategorized according to quartiles. bCategorized accord-
ing to tertiles. cCategorized according to median, 75th,
and 90th percentiles. dCategorized according to regula-
tory considerations.
Table 4. Leukemia risk by alternate benzene exposure
metrics.
No.
exposed Odds
cases ratio 95% Cl
Benzene intensity,
mean ppm
0-0.01 9 1.00
>0.01-0.19 2 0.88 0.08-6.47
0.20-0.49 1 0.19 0-1.55
0.50-6.16 2 0.96 0.09-6.81
Maximum benzene
intensity, ppm
<0.5 10 1.00
0.5-0.99 0 0 0-7.57
1.0+ 4 1.02 0.21-4.26
Maximum probability
of dermal exposure
Low 8 1.00
Medium 4 0.61 0.12-2.51
High 2 0.47 0.04-2.86
exposure group, although the confidence
intervals are extremelywide.
Leukemia risk according to other expo-
sure metrics is shown in Table 4. Risk did
not increase in a consistentway for the mean
intensity over a worker's career, for workers
ever exposed between 0.5 and 1 ppm or
over 1 ppm, nor by a worker's highest
ranked probability ofdermal exposure.
ORs andp-values for coefficients in the
logistic models were very similar when
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exposures were lagged for 0, 5, 10, or 15
years. Therefore, we will report results only
for no lag period.
Cumulative benzene exposure did not
show a strong relationship with leukemia
when regressed separately (OR= 1.002/
pprn-year, p= 0.77). The p-value for the
score statistic (p=0.76) indicates that this
model does not fit the data well (Table 4,
model 1). We also added into the model
separate terms for an employee's mean
exposure intensity and total exposure dura-
tion. This maneuver produced a noninter-
pretable result; exposure intensity (OR=
2.27/ppm) and duration (OR= 1.07/year)
showed a positive relationship, yet the OR
for cumulative exposure fell below 1.0
(Table 5). A model with only exposure
duration showed a coefficient of 1.06/year
exposed with a 95% confidence interval of
0.99 to 1.14 (Table 5, model 4) and
resulted in a reasonable overall model p-
value (p=0.10). Thus, for these data, the
simple measure of exposure duration was
most closely associated with leukemia,
while cumulative benzene exposure and
mean intensity of benzene exposure did
not explain leukemia risk.
Next we examined whether exposure
above a certain level was related to leukemia
risk, by using the number ofyears worked
above either 0.5 or 1 ppm as independent
variables. Neither of these variables
explained leukemia risk adequately nor fit
the data well (Table 5, models 5,6). The
coefficient for years above 0.5 ppm (1.02)
was slightly greater than the coefficient for
years above 1 ppm (1.00).
The number of years spent in jobs
ranked as having a low, medium, or high
probability ofdermal exposure was explored
in one model. The risks were higher (and
closer to significance) for a year spent in a
low-probability job (OR = 1.06/year,
p= 0. 14) versus a high probability job
(OR = 1.02/year,p=0.76).
Since the Mantel-Haenszel analyses
showed that leukemia risk did not increase
for increasing categories of cumulative
exposure, we constructed models with
square terms for duration and intensity of
exposure. This allows for nonexponential
increases in risk per unit exposure. For all
combinations ofduration and intensity of
exposure, and the squares ofthese variables,
a model with only duration of exposure
squared fit the data best (p = 0.05). The
OR for this model (1.001/year2) was not
quite statistically significant (p =0.07).
Since both cigarette smokingand afamily
history of cancer were related to leukemia
Table 5. Conditional logistic regression modeling results for leukemia and benzene exposure.
Model Odds 95% Lower 95% Upper Variable
Model p-valuea Variable ratio limit limit p-valueb
1 0.76 Cumulative benzene exposure 1.002 0.989 1.015 0.77
2 0.28 Cumulative benzene exposure 0.980 0.933 1.030 0.43
Mean intensity 2.271 0.426 12.098 0.34
Duration 1.069 0.990 1.155 0.09
3 0.50 Intensity 1.171 0.729 1.880 0.51
4 0.10 Duration 1.061 0.985 1.144 0.12
5 0.70 Years at 0.5+ ppm 1.015 0.940 1.095 0.71
6 0.93 Years at 1.0+ ppm 1.004 0.921 1.094 0.93
7 0.38 Years at low dermal 1.061 0.984 1.144 0.14
Years at medium dermal 1.054 0.954 1.164 0.30
Years at high dermal 1.022 0.895 1.167 0.75
8Based on score statistic. bBased on Wald chi-square statistic.
Table 6. Conditional logistic modeling results for leukemia for cases and controls with known values for potential
confounders.
Model
1
2
Model
p-valuea
0.11
0.02
3 0.06
4 0.06
5 0.03
6 0.04
Variable
Family history of cancer
Family history of cancer
Ever smoked cigarettes
Family history of cancer
Ever smoked cigarettes
Cumulative benzene exposure
Family history of cancer
Ever smoked cigarettes
Intensity
Family history of cancer
Ever smoked cigarettes
Duration
Family history of cancer
Ever smoked cigarettes
Duration
Duration squared
Odds
ratio
5.53
14.0
8.89
11.5
6.93
0.97
11.2
7.99
0.34
18.8
15.1
1.08
16.5
13.0
0.82
1.01
95% Lower
limit
0.54
1.04
0.66
0.83
0.48
0.82
0.81
0.55
0
1.33
0.61
0.95
1.11
0.37
0.43
0.99
95% Upper
limit
56.6
188.0
119.0
160.0
100.0
1.15
119.0
115.0
26.5
265.0
376.0
1.22
244.0
455.0
1.57
1.02
Variable
p-valueb
0.15
0.05
0.10
0.07
0.16
0.72
0.07
0.13
0.63
0.05
0.12
0.25
0.04
0.16
0.55
0.49
"Based on score statistic. bBased on Wald chi-square statistic.
in the Mantel-Haenszel analyses, we con-
structed a series ofmodels among cases and
controls forwhich we had known values for
these variables. We then added cumulative
exposure, exposure intensity, and years
exposed to these models. Since these mod-
els are performed on a different set ofcases
and controls, the results should not be com-
pared to those in Table 5. Table 6 shows
results from the model with only the poten-
tial confounders (an employee's family his-
tory ofcancer and whether he ever smoked
cigarettes). This model produced high but
unstable ORs (OR= 14.0 and 8.9, respec-
tively) for each variable. The score statistic
indicated that the model fit was statistically
significant (p = 0.02). Next, we added
different combinations ofcumulative ben-
zene exposure, mean intensity of benzene
exposure, duration of exposure, and the
square of the latter two variables. None of
the expanded models resulted in a better fit
to the data, as measured by the score statis-
tic. Adding cumulative benzene exposure to
this model resulted in an OR for benzene of
0.97/ppm-year, and reduced the score test
significance from 0.02 to 0.06 (Table 6).
Only when duration of exposure squared
was added did the model again achieve sta-
tistical significance (score test p-value =
0.04). All ofthese models resulted in ORs
for cumulative benzene exposure and mean
benzene intensity ofless than 1.0, and ORs
for duration ofexposure ofgreater than 1.0,
but none of the exposure variables were
statistically significant (p>0.25).
Thus, these results show that a family
history ofcancer and cigarette smoking are
the two strongest risk factors in these data.
Cumulative benzene exposure did not
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explain any incremental risk in leukemia
when added to a model with these two
risk factors.
Discussion
In general, this study did not find evidence
that low-level exposure to benzene increased
the risk ofleukemia. However, the inter-
pretation of this study must take into
account its limited size. If benzene expo-
sure caused a 2-fold increase in risk for the
>45 ppm-year category, this study would
have a 16% chance of detecting this at a
20% exposure rate and a 5% significance
level. For 80% power, 90 cases would be
needed. Despite the study's small size, it is
useful to focus on the pattern of results,
with emphasis on the magnitude ofthe risk
estimates, rather than their precision.
We did not find a dose-response
relationship between leukemia cases and
any offive classifications ofcumulative ben-
zene exposure. Alternate exposure metrics,
including average exposure intensity, years
ofexposure above 0.5 or 1 ppm, or a ranked
estimate ofdermal exposure also did not
show a dose-response pattern. Duration of
exposure produced the best goodness offit
statistic among the models with only expo-
sure variables, but was not statistically
significant. These results are most consis-
tent with insufficient power to detect a
small effect, or a lack of effect for low
benzene exposures (primarily between 0.1
and 1.0 ppm).
The strongest risk factors were non-
occupational (smoking and a family history
of cancer). However, these data were
not present for all workers in the study,
and need to be interpreted cautiously.
Despite incomplete information, this study
does raise a question on the relevancy of
tobacco use on the occurrence ofleukemia.
Siegel et al. (17) suggested that smoking
increases the risk of myeloid leukemia by
50%. The limited amount of smoking
information, and the incomplete records
prevented the assessment of interaction
between benzene and smoking. Future
studies of low-dose benzene exposures
should also attempt to measure smoking
habits to shed further light on the meaning
ofthese preliminary results.
We also found that a family history of
cancer was a significant predictor ofleuke-
mia risk. However, since our records came
from pre-employment physicals, supple-
mented by notes from periodic physical
exams, the findings must be interpreted
with caution. Leukemia has been related to
a positive family history of other cancers,
but not consistently. Tajima (18) found a
raised incidence ofT-cell leukemia in per-
sons with a family history of any cancer,
which was stronger in those with a family
history ofhematopoietic malignancies. Our
measure offamily history included any can-
cers in parents, siblings, and children. Only
two ofthe cancers were leukemia.
The fact that duration ofexposure was
more strongly related to leukemia occur-
rence than either exposure intensity or
cumulative exposure could indicate that
long-term exposure, regardless of the con-
centration, can result in leukemia. Another
interpretation is that this is the best expo-
sure metric because it is measured with the
most precision. However, this would imply
that the considerable effort to classify
intensity of exposure actually resulted in
severe misclassification, even between the
highest and lowest intensity designations.
We regard this as highly unlikely, partly
due to the exposure assessment validation
exercise (14). Finally, one could regard the
finding as the chance result of examining
many different exposure metrics, and that
it has no biological significance.
Subpopulations represented in previous
studies may have been exposed to similar
benzene exposure levels to those present in
the current study. The following risks per-
tain to levels up to 83 ppm-years, or about
2 ppm for 40 years. Wong (19) reported
slight deficits in SMRs of 0.97 (0-14.9
ppm-years), and 0.78 (15-59.9 ppm-
years). Bond et al. (20) reported an SMR
of 1.67 for workers exposed to less than 42
ppm-years, but found no cases in those
exposed between 42 and 83 ppm-years.
Finally, Paxton et al. (6), reported SMRs
of 1.33 in workers exposed to 5 or fewer
5- B=Bond
X = This study
4 - P = Paxton
W = Wong
e 3-
Cc 2 BP.
P* 1- WWX
0 X X B
0.1 1 10 100 1000
Cumulative exposure, ppm/year
Figure 1. Leukemia risk by cumulative benzene expo-
sure, four studies. Asterisk (*) indicates risk at 11.9.
ppm-years, and 1.79 in workers exposed
between 5 and 50 ppm-years. The present
study, along with these other studies, sug-
gests that risks under about 50 ppm-years
are either small or nonexistent. However,
these data cannot be used to rule out a risk
at these levels, since the risk estimates are
based on relatively few workers.
The relevant studies are summarized in
Figure 1. The figure shows that for expo-
sures under approximately 100 ppm-years,
the risks for total leukemia reported in four
studies are approximately evenly distrib-
uted around 1.0.
For higher exposures (generally above
60 ppm-years), higher risks have been doc-
umented. Paxton et al. (6) reported SMRs
of2.80 for exposures from 50 to 500 ppm-
years, Wong (19) reported an SMR of
2.76 for 60 ppm-years or greater, and
Bond et al. (20) reported an SMR of 2.50
for 83+ ppm-years. Thus, one could argue
that exposures in this range produce a 2- to
3-fold riskofleukemia (Figure 1).
Previous epidemiologic studies in which
benzene exposure has been quantified have
been limited by the small number of
leukemia cases observed. The most-studied
worker cohort now consists of 15 leukemia
cases, including one female case (6). Other
cohorts had only 5 (20) and 6 (19) cases of
leukemia. Thus, the 14 leukemia cases rep-
resented in this study is a significant contri-
bution, especially for exposures below 50
ppm-years. At the very least, this study can
be used to provide a check on risk predic-
tions forlower levels ofbenzene exposure.
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